Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Sensitivity, Specificity, and Predicted Value

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Interplay of Lifestyle Social Determinants and Isolation in the Risk of Metabolic Syndrome Among Spanish Workers.

Cureus·2026

Same author

Does provable absence of barren plateaus imply classical simulability?

Nature communications·2025

Same author

Quantum-inspired clustering with light.

Scientific reports·2024

Same author

Variational quantum and quantum-inspired clustering.

Scientific reports·2023

Same author

Variational quantum non-orthogonal optimization.

Scientific reports·2023

Same author

Incidence, clinical features and outcomes of atrial fibrillation and stroke in Qatar.

International journal of stroke : official journal of the International Stroke Society·2019

Same journal

Circulating miR-107, miR-199, and miR-485 Have High Diagnostic Potential in Non-small Cell Lung Cancer: An Exploratory Study.

Clinical Medicine Insights. Oncology·2026

Same journal

The Impacts of Diabetes Mellitus on Clinical Outcomes of Hospitalization Following Craniotomy for Brain Tumor.

Clinical Medicine Insights. Oncology·2026

Same journal

Augmented Reality Navigation-Assisted Laparoscopic Hepatectomy: A Retrospective Comparison of Anatomical and Non-anatomical Resection.

Clinical Medicine Insights. Oncology·2026

Same journal

Unveiling ER-Phagy Receptors in Thyroid Cancer: A Combined Approach of Public Data Mining and In Vitro Validation.

Clinical Medicine Insights. Oncology·2026

Same journal

Magnetic Resonance Imaging Features as Predictors of Response and Prognosis Following Neoadjuvant Therapy in Rectal Cancer: A Retrospective Cohort Study.

Clinical Medicine Insights. Oncology·2026

Same journal

Initial Low-Dose Dacomitinib for First-Line Treatment of Patients With EGFR Exon 21-Mutated Non-Small-Cell Lung Cancer.

Clinical Medicine Insights. Oncology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 16, 2026

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

Development of Interpretable Predictive Models for BPH and Prostate Cancer.

Pablo Bermejo¹, Alicia Vivo², Pedro J Tárraga²

¹Escuela Superior de Ingeniería Informática, Universidad de Castilla-La Mancha, Albacete, Spain.

Clinical Medicine Insights. Oncology

|March 18, 2015

Summary

This summary is machine-generated.

New predictive models accurately distinguish prostate cancer (PC) from benign prostate hyperplasia (BPH) using prostate volume and PSA. These models can help reduce unnecessary prostate biopsies.

Keywords:

benign prostate hyperplasia observational study primary care prostate biopsy prostate cancer prostate pathology prediction

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Identification, Histological Characterization, and Dissection of Mouse Prostate Lobes for In Vitro 3D Spheroid Culture Models

Identification, Histological Characterization, and Dissection of Mouse Prostate Lobes for In Vitro 3D Spheroid Culture Models

Published on: September 18, 2018

Related Experiment Videos

Last Updated: Apr 16, 2026

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Identification, Histological Characterization, and Dissection of Mouse Prostate Lobes for In Vitro 3D Spheroid Culture Models

Identification, Histological Characterization, and Dissection of Mouse Prostate Lobes for In Vitro 3D Spheroid Culture Models

Published on: September 18, 2018

Area of Science:

Urology
Medical Informatics
Oncology

Background:

Traditional prostate biopsy recommendations rely on prostate-specific antigen (PSA) cut-offs.
Existing predictive models for prostate cancer (PC) struggle to differentiate between PC and benign prostate hyperplasia (BPH).

Purpose of the Study:

To develop and validate novel predictive models capable of distinguishing between PC and BPH.
To improve diagnostic accuracy and reduce unnecessary prostate biopsies.

Main Methods:

An observational study included 150 patients aged over 50 with PSA ≥3 ng/mL.
A decision tree and a logistic regression model were constructed and validated using leave-one-out methodology.
Models predicted PC, BPH, or rejection of both diagnoses.

Main Results:

Prostate volume, PSA, International Prostate Symptom Score (IPSS), digital rectal examination (DRE), age, antecedents, and meat consumption showed statistical dependence with PC and BPH.
The developed models, utilizing volume, PSA, DRE, and IPSS, achieved an Area Under the ROC Curve (AUC) between 72% and 80% for both PC and BPH prediction.
These models demonstrated superior AUC compared to previously reported studies.

Conclusions:

Combined PSA and prostate volume are key components for accurate predictive models differentiating PC, BPH, and other conditions.
The decision tree and logistic regression models offer improved diagnostic performance.
Implementing these models as decision support tools can significantly decrease the rate of unnecessary prostate biopsies.